P300 cognitive potencial on subjects with diabetes mellitus;Potencial cognitivo P300 em indivíduos com diabetes mellitus

Revista Brasileira de Otorrinolaringologia

Volumn 71, Issue 2, 2005, Pages 202-207

  De Freitas Alvarenga, Kátia ^a,c   Duarte, Josilene Luciene ^a   Camargo Da Silva, Daniela Polo ^b   Agostinho Pesse, Raquel Sampaio ^b   Negrato, Carlos Antonio ^b   Alves Costa, Orozimbo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Departamento de Fonoaudiologia Profa Dra Kátia de Freitas Alvarenga   (Brazil)

Author keywords

Audiometry; Diabetes mellitus; Event related potentials; Hearing loss; P300

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDITORY CORTEX; BRAIN CORTEX; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIAL NERVE; DIABETES MELLITUS; DIAGNOSTIC VALUE; EAR; EARLY DIAGNOSIS; EVENT RELATED POTENTIAL; EVOKED RESPONSE; EYE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; MALE; NEUROLOGIC DISEASE; PERIPHERAL NERVE; PURE TONE AUDIOMETRY; SCHOOL CHILD; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; CHILD; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; HEARING LOSS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AUDITORY CORTEX; CHILD; COGNITION; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC NEUROPATHIES; EVENT-RELATED POTENTIALS, P300; FEMALE; HEARING LOSS; HUMANS; MALE; MIDDLE AGED;

EID: 20344373160     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992005000200014     Document Type: Article

References (16)

1. Jerger S, Jerger J. Diabetes Mellitus. In: Jerger S, Jerger J. Alterações auditivas: Um manual para avaliação clínica. Ed. Atheneu, 1998. pp. 35-9.
2. Huang Y. Study on the hearing impairment in diabetic patients. Zhonghua Er Bi Yan Hou Ke Za Zhi 1990; 25 (6): 354-6.
3. Huang YM, Pan CY, Gu R, Cai XH, Yu LM, Qiu CY. Hearing impairment in diabetes. Chin Med J Engl 1992; 105 (1): 44-8.
4. Goldsher M, Pratt H, Hassan A, Shenhav R, Eliachar I, Kanter Y. Auditory brainstem evoked potentials in insulin-dependent diabetes with and without peripheral neuropathy. Acta Otolaryngol 1986; 102 (3-4): 204-8.
5. Lisowska G, Namyslowskí G, Morawski K, Strojek K. Early identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurotol 2001; 22 (3): 316-20.
6. Kurita A, Mochio S, Isogai Y. Changes in auditory P300 event-related potentials and brainstem evoked potentials in diabetes mellitus. Acta Neurol Scand 1995; 92 (4): 319-23.
7. Jorgensen M, Buch N. Studies on inner ear function and cranial nerves in diabetics. Acta Otolaryngol 1991; 53: 350.
8. Di Leo MA, Di Nardo W, Cercones S, Ciervo A, Lo Monaco M, Greco AV, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997; 20 (11): 1800-3.
9. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998; 21: 379-84.
10. Picton T W. The P300 wave of the human event-related potential. J Clin Neurophysiol 1992; 9: 456-79.
11. Auer RN, Siesjo BK. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 1993; 7: 611-25.
12. Pozzesssere G, Valle E, De Crignis S, Cordischi VM, Fattapposta F, Rizzo PA, et al. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Diabetes 1991; 40: 952-58.
13. Tandon OP, Verma A, Ram BK. Cognitive dysfunction in NIDDM: P3 event related evoked potential study. Indian J Physiol Pharmacol 1999; 43 (3): 383-8.
14. Hissa MN, D'Almeida JA, Cremasco F, De Bruin VM. Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes. Neuroendocrinol Lett 2002; 23 (3): 226-30.
15. De Feo P, Gallai V, Mazzotta G, Crispino G, Torlone E, Perriello G, et al. Modest decrement in plasma glucose concentration causes early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 1988; 82: 436-44.
16. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complication. N Engl J Med 1988; 318: 1315-21.